The ’s Biomedical and Chemical Engineering department will host “Advancing Convergence and Innovation in Cancer Research,” as part of the Graduate Student Seminar Series on Friday, Sept. 19, in Link Hall, Room 105 from 1-2 p.m.
Jerry S.H. Lee
Representatives for the National Cancer Institute’s (NCI) Center for Strategic Scientific Initiatives (CSSI), including Health Services Director Jerry S.H. Lee, will highlight their programs and accomplishments, including the Clinical Proteomic Tumor Analysis Consortium, the Alliance for Nanotechnology in Cancer, Physical Sciences-Oncology Centers, Innovative Molecular Analysis Technologies and Provocative Questions.
The seminar is open to anyone interested in learning more about the NCI’s CSSI. For more information, contact Professor Jesse Bond.
鶹Ƶ the NCI CSSI
The CSSI is a component of the NCI’s Office of the Director focused on emerging advanced technologies that have the potential of uniquely impacting the full spectrum of basic and clinical cancer research.
The center is tasked with planning, developing, executing and implementing rapid strategic scientific and technology initiatives that keep the institute ahead of the scientific curve with respect to potential new exciting areas and discoveries. This may involve direct development and application of advanced technologies, synergy of large-scale and individual initiated research and/or using available federal mechanisms to forge novel partnerships that emphasize innovation, cross-disciplinary teams and convergence of scientific disciplines.
With an emphasis on complementing the scientific efforts of other NCI divisions, CSSI’s efforts seek to enable the translation of discoveries into new interventions, both domestically and in the international arena, to detect, prevent, and treat cancer more effectively.
